The 21st Century Cures Act has cleared a major Senate hurdle and is expected to be signed into law by President Obama. Among other provisions, the bill will fast-track the approval process for certain drugs and medical devices. The $6.3 billion package includes “nearly $5 billion for the National Institutes of Health to accelerate research into major diseases, including $1.8 billion for Vice President Joseph R. Biden’s “moonshot” project on cancer, and $500 million for the Food and Drug Administration to make its approval process more efficient.”
The act gives hope to many patients who don’t have time to wait for lengthy testing and approvals. At the same time, many observers have pointed out the potential that these innovative new drugs and devices could come with more complications than those that have undergone extensive testing, which could lead to more recalls.
Now is a good time for pharmaceutical and medical device companies to revisit recall preparation, including:
Many in the industry are optimistic about the promise of the 21st Century Cures Act. But it also means companies will be entering into uncharted waters. To successfully navigate those potentially choppy seas, they must ensure lifeboats are adequate – and that means testing and updating recall plans.
Stay on top of the latest in Recalls with Expert Solutions! Our Quarterly Recall Index insights keep you up-to-date with recall trends, while our blogs and Expert Spotlight provide timely information from industry specialists.Subscribe Now
Stericycle Expert Solutions focuses on helping customers by providing proven, customer-centric, scalable services that protect people and brands, promote health and safeguard the environment.Find Out More
If you're ready to get started with our extensive suite of services then contact us today. We have a team of experts ready to assist you!Contact Us today